Mifepristone-misoprostol - change to listing - EML

被引：0
|
作者：
机构：
来源：
SELECTION AND USE OF ESSENTIAL MEDICINES: REPORT OF THE WHO EXPERT COMMITTEE ON SELECTION AND USE OF ESSENTIAL MEDICINES, 2019 (INCLUDING THE 21ST WHO MODEL LIST OF ESSENTIAL MEDICINES AND THE 7TH WHO MODEL LIST OF ESSENTIAL MEDICINES FOR CHILDREN) | 2019年 / 1021卷
关键词：
MEDICAL ABORTION; TERMINATION; PROVISION; PROVIDERS; SAFETY; CARE;
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：422 / 428
页数：7
相关论文
共 50 条
  • [21] Mifepristone-misoprostol midtrimester abortion: impact of gestational age on the induction-to-abortion interval
    Gomez, Olga
    Borras, Aina
    Rabanal, Aintzane
    Palacio, Montse
    Carceller, Antonia
    Coll, Oriol
    Gratacos, Eduard
    CONTRACEPTION, 2010, 81 (02) : 97 - 101
  • [22] Could American women use mifepristone-misoprostol pills safely with less medical supervision?
    Harper, C
    Ellertson, C
    Winikoff, B
    CONTRACEPTION, 2002, 65 (02) : 133 - 142
  • [23] Alternatives to routine ultrasound for eligibility assessment prior to early termination of pregnancy with mifepristone-misoprostol
    Bracken, H.
    Clark, W.
    Lichtenberg, E. S.
    Schweikert, S. M.
    Tanenhaus, J.
    Barajas, A.
    Alpert, L.
    Winikoff, B.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2011, 118 (01) : 17 - 23
  • [24] Termination of early pregnancy using flexible, low-dose mifepristone-misoprostol regimens
    Heikiaelmo, Oskari
    Leminen, Riikka
    Sullonen, Satu
    CONTRACEPTION, 2007, 76 (06) : 456 - 460
  • [25] Blood loss with mifepristone-misoprostol abortion: measures from a trial in China, Cuba and India
    Harper, C
    Winikoff, B
    Ellertson, C
    Coyaji, K
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1998, 63 (01) : 39 - 49
  • [26] Comparison of misoprostol-only and combined mifepristone-misoprostol regimens for home-based early medical abortion in Tunisia and Vietnam
    Blum, Jennifer
    Raghavan, Sheila
    Dabash, Rasha
    Nguyen Thi Nhu Ngoc
    Chelli, Hela
    Hajri, Selma
    Conkling, Kathryn
    Winikoff, Beverly
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2012, 118 (02) : 166 - 171
  • [27] Efficacy and acceptability of early mifepristone-misoprostol medical abortion in Ukraine: Results of two clinical trials
    Raghavan, Sheila
    Maistruk, Galina
    Shochet, Tara
    Bannikov, Vladimir
    Posohova, Svetlana
    Zhuk, Svetlana
    Lishchuk, Vladimir
    Winikoff, Beverly
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2013, 18 (02): : 112 - 119
  • [28] VITAMINS AND MINERALS Iodine - change to listing - EML and EMLc
    SELECTION AND USE OF ESSENTIAL MEDICINES: REPORT OF THE WHO EXPERT COMMITTEE ON SELECTION AND USE OF ESSENTIAL MEDICINES, 2019 (INCLUDING THE 21ST WHO MODEL LIST OF ESSENTIAL MEDICINES AND THE 7TH WHO MODEL LIST OF ESSENTIAL MEDICINES FOR CHILDREN), 2019, 1021 : 463 - 464
  • [29] Feticide Followed by Mifepristone-Misoprostol Regimen for Midtrimester Termination of Pregnancy in Two Cases of Complete Placenta Previa
    Borras, A.
    Gomez, O.
    Sanz, M.
    Martinez, J. M.
    Puerto, B.
    FETAL DIAGNOSIS AND THERAPY, 2010, 28 (02) : 114 - 116
  • [30] Feasibility, efficacy, safety, and acceptability of mifepristone-misoprostol for medical abortion in the Democratic People's Republic of Korea
    Tran, Nguyen Toan
    Jang, Myong Chon
    Choe, Yong Su
    Ko, Won Su
    Pyo, Hae Suk
    Kim, Ok Suk
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2010, 109 (03) : 209 - 212
12345